RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

DNA Funded vs FundedElite

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

DNAF

DNA Funded

FUNDE2

FundedElite

EST. 2023

DNA FUNDED

METRIC

FUNDEDELITE

0/100—

TRUST SCORE

BETTER58/100

0/5—

RATING

BETTER3/5

—

PROFIT SPLIT

80%

—

MAX FUNDING

$300,000

—

MIN COST

$39

—

PAYOUT DAYS

—

PASS RATE

—

0—

REVIEW COUNT

BETTER1

DNA FUNDED DETAILS

STEPS: -phase

FUNDEDELITE DETAILS

STEPS: 2-phase
DRAWDOWN: Fixed
MARKETS: Forex, Crypto, Metals, Indices, Commodities, Equities
PLATFORMS: MT5, TradeLocker, cTrader

DNA Funded PROS

+No performance data is available to identify any above-average metrics for this firm
+No fee, payout, or structure data provided to evaluate competitiveness
+No platform or market data available to assess trading flexibility
+Country of operation (Australia) is noted, but no regulatory or structural data exists

DNA Funded CONS

−No data is provided for this firm, making any meaningful comparison impossible
−Traders cannot assess profit split, funding, or costs against the 84.7% and $186.7 averages
−Complete absence of data is a significant transparency concern for traders making financial decisions

FundedElite PROS

+Minimum challenge cost of $39 is well below the industry average of $186.7.
+Days to first payout of 3 is faster than the industry average of 6.5 days.
+Supports 6 asset classes including Forex, Crypto, Metals, Indices, Commodities, and Equities.
+On-demand payouts, weekend holding, news trading, and EA use are all permitted.

FundedElite CONS

−Profit split of 80% is below the industry average of 84.7%.
−Max funding of $300,000 is significantly below the industry average of $839,272.7.
−Overall drawdown of 8% is slightly above the industry average of 7.9%, offering marginally less buffer.

PROPDNA VERDICT

DNA Funded

Lower trust score (0/100). Slower payouts at —d.

START WITH DNAF